A Combination of Docking/Dynamics Simulations and Pharmacophoric Modeling To Discover New Dual c-Src/Abl Kinase Inhibitors
- 6 May 2006
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (11), 3278-3286
- https://doi.org/10.1021/jm060236z
Abstract
A computational protocol was applied to identify molecular scaffolds untested toward the c-Src tyrosine kinase. A combination of docking and dynamics calculations allowed us to build three-dimensional models of the complexes between Src and several of its known inhibitors. Interactions most contributing to activity of the inhibitors, in terms of hydrogen bonds and hydrophobic contacts, were codified into pharmacophoric models that were in turn applied to perform a search of commercially available compounds within the Asinex database. As a result, we identified 1,3,4-thiadiazoles and pyrazolydine-3,5-diones showing inhibitory activity in the submicromolar range in a cell-free assay toward Src. Moreover, since several of the compounds used to generate pharmacophores were also known as Abl inhibitors, we tested the identified hits toward Abl tyrosine kinase, finding activity in the submicromolar range. Such biological data suggested that the computational protocol is an efficient tool for identifying new hits toward both Src and Abl.Keywords
This publication has 17 references indexed in Scilit:
- Further studies on ethenyl and ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of a subnanomolar Src kinase inhibitorBioorganic & Medicinal Chemistry Letters, 2005
- Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CMLBlood, 2004
- New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylationBioorganic & Medicinal Chemistry Letters, 2004
- Molecular Basis for the Binding of Competitive Inhibitors of Maize Polyamine OxidaseBiochemistry, 2004
- Pyrazolo[3,4-d]pyrimidines Endowed with Antiproliferative Activity on Ductal Infiltrating Carcinoma CellsJournal of Medicinal Chemistry, 2004
- Structural Basis for the Autoinhibition of c-Abl Tyrosine KinaseCell, 2003
- v-SRC'S hold over actin and cell adhesionsNature Reviews Molecular Cell Biology, 2002
- The hunting of the SrcNature Reviews Molecular Cell Biology, 2001
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor: STUDY OF Lck- AND FynT-DEPENDENT T CELL ACTIVATIONOnline Journal of Public Health Informatics, 1996
- Expression of pp60c-src in human small cell and non-small cell lung carcinomasEuropean Journal of Cancer, 1992